3um Streptavidin Magnetic Beads MSA3UM-10 1%

3µm Streptavidin Magnetic Beads MSA3UM-10

MSA3UM-10 is a 3µm streptavidin-functional magnetic bead suspension supplied at 1% solids.

When the solids concentration is expressed as weight per volume, 1% corresponds to approximately 10mg of magnetic beads per milliliter of suspension.

The product is developed for the capture and immobilization of biotinylated antibodies, antigens, proteins, peptides, aptamers, oligonucleotides and other biotin-labelled biomolecules.

MSA3UM-10 can be evaluated as a magnetic solid phase in chemiluminescence immunoassay development, magnetic immunoassay research, biomolecule enrichment, sample preparation, process scale-up and batch reagent manufacturing.

Streptavidin immobilized on the magnetic bead surface binds biotinylated ligands without requiring the end user to activate the beads using EDC, NHS, glutaraldehyde or another chemical activation reagent.

After loading the selected biotinylated capture ligand, the functionalized beads can be used for target capture, magnetic separation, repeated washing and downstream signal detection.

MSA3UM-10 is intended for biotechnology companies, immunoassay developers, research institutions and reagent manufacturers requiring a defined 3µm streptavidin magnetic bead raw material for laboratory evaluation, pilot production and bulk supply.

The finished reagent should be validated using the intended biotinylated ligand, sample matrix, magnetic separator, wash program, signal chemistry and immunoassay analyzer.

Product Overview

The streptavidin–biotin system provides a flexible method for immobilizing different biotinylated biomolecules on a common magnetic solid phase.

Commercial exact-3µm streptavidin magnetic beads are supplied at approximately10mg/mL and are positioned for capturing biotinylated antibodies, proteins and nucleic acids, as well as for automated high-throughput workflows.

MSA3UM-10 is designed to support:

• Biotinylated antibody immobilization;

• Biotinylated antigen immobilization;

• Magnetic sandwich immunoassays;

• Antibody-detection assays;

• Competitive immunoassays;

• Chemiluminescence immunoassay development;

• Electrochemiluminescence assay research;

• Immunomagnetic enrichment;

• Biotinylated peptide capture;

• Nucleic acid and aptamer capture;

• Automated reagent development;

• Pilot-scale manufacturing;

• Batch production.

MSA3UM-10 is supplied as a research and reagent-development raw material. It is not supplied as a finished diagnostic reagent.

MSA3UM-10 Product Specifications

The following product-specific parameters should be confirmed through the applicable technical data sheet and lot-specific certificate of analysis:

• Particle-size distribution;

• Streptavidin loading;

• Streptavidin activity;

• Free biotin-binding capacity;

• Biotinylated antibody-loading capacity;

• Biotinylated oligonucleotide-loading capacity;

• Non-specific binding;

• Magnetic collection performance;

• Suspension buffer;

• Blocking formulation;

• Preservative system;

• Storage conditions;

• Shelf life;

• Lot-release criteria.

Competitor binding-capacity values should be used only for market benchmarking. They should not be presented as specifications for MSA3UM-10.

How Do Streptavidin Magnetic Beads Work?

Streptavidin immobilized on the magnetic bead surface provides binding sites for biotin.

When a biotinylated antibody, antigen, protein, peptide or oligonucleotide is incubated with MSA3UM-10, the biotin group binds to the surface streptavidin.

The resulting structure can be represented as:

Magnetic bead–streptavidin–biotin–ligand

The biotinylated ligand provides biological target recognition, while the magnetic particle provides a solid phase for collection, washing and reagent handling.

Commercial streptavidin-coated magnetic particles are used for separating biotinylated proteins, immunoglobulins, DNA, RNA and other biotin-labelled molecules.

Example Using a Biotinylated Capture Antibody

A magnetic sandwich immunoassay may include the following steps:

1. Prepare a biotinylated capture antibody.

2. Incubate the antibody with MSA3UM-10.

3. Allow the biotin groups to bind to surface streptavidin.

4. Magnetically collect the antibody-loaded beads.

5. Remove the unbound antibody.

6. Resuspend the loaded beads in the selected formulation.

7. Incubate the beads with the sample.

8. Capture the target antigen.

9. Add a labelled detection antibody.

10. Magnetically collect and wash the immune complex.

11. Add or trigger the selected signal reagent.

12. Measure the analytical signal.

Example Using a Biotinylated Antigen

For an antibody-detection assay:

1. Prepare a biotinylated antigen.

2. Load the antigen onto MSA3UM-10.

3. Remove unbound antigen.

4. Incubate the antigen-loaded beads with the sample.

5. Capture target-specific antibodies.

6. Add a labelled secondary antibody.

7. Perform magnetic washing.

8. Measure the resulting signal.

Example Using a Biotinylated Oligonucleotide

A biotinylated oligonucleotide may be immobilized for:

• Nucleic acid capture;

• Hybridization assays;

• Aptamer-based detection;

• Target enrichment;

• Probe immobilization;

• Molecular diagnostic research;

• Pull-down experiments;

• Sample preparation before amplification.

The position and degree of biotinylation should be selected to preserve hybridization or target-recognition activity.

Key Features of MSA3UM-10

Defined 3µm Particle Size

MSA3UM-10 provides a defined 3µm magnetic particle format rather than a broad micrometer-scale range.

Particle size can influence:

• Particle number per unit mass;

• Available geometric surface area;

• Ligand accessibility;

• Sedimentation;

• Magnetic collection;

• Collection-zone formation;

• Washing efficiency;

• Redispersion;

• Automated liquid handling.

Actual performance also depends on magnetic material content, particle-size distribution, surface coating, streptavidin density, suspension buffer and magnet configuration.

Streptavidin-Functional Surface

The surface provides affinity-binding sites for biotinylated ligands.

Potential ligands include:

• Biotinylated monoclonal antibodies;

• Biotinylated polyclonal antibodies;

• Biotinylated recombinant antigens;

• Biotinylated natural proteins;

• Biotinylated peptides;

• Biotinylated enzymes;

• Biotinylated aptamers;

• Biotinylated DNA probes;

• Biotinylated RNA probes;

• Biotinylated haptens;

• Other biotin-labelled affinity molecules.

1% Solids Formulation

When expressed as w/v, the 1% solids suspension corresponds to approximately 10mg/mL.

Approximate bead-mass calculations are:

• 10µL contains approximately 0.1mg of beads;

• 50µL contains approximately 0.5mg of beads;

• 100µL contains approximately 1mg of beads;

• 500µL contains approximately 5mg of beads;

• 1mL contains approximately 10mg of beads.

These calculations should only be used after confirming that the product’s 1% specification is expressed as w/v.

Exact-3µm competitors are also available at10mg/mL, making this a familiar concentration for competitive comparison and method development.

No Additional Bead Activation Required

A properly biotinylated ligand can normally be loaded without activating the magnetic bead surface using EDC/NHS or another covalent coupling reagent.

This can simplify early assay development because different biotinylated capture molecules can be compared on the same bead platform.

Flexible Ligand Screening

MSA3UM-10 can be evaluated with multiple biotinylated antibodies, antigens or probes.

This supports:

• Capture-antibody screening;

• Antibody-pair comparison;

• Antigen-construct evaluation;

• Peptide screening;

• Aptamer screening;

• Assay-target expansion;

• Multiproduct reagent development.

Magnetic Solid-Phase Processing

After ligand loading and target capture, the particles can be collected using a compatible magnetic separator.

A typical process includes:

• Bead dispensing;

• Sample incubation;

• Target capture;

• Magnetic collection;

• Supernatant removal;

• Washing;

• Detection-reagent incubation;

• Additional magnetic washing;

• Signal generation.

Research-to-Production Supply

MSA3UM-10 can support:

• Initial feasibility evaluation;

• Biotinylated ligand screening;

• Immunoassay optimization;

• Automated-analyzer evaluation;

• Stability studies;

• Pilot manufacturing;

• Lot-consistency assessment;

• Bulk raw-material procurement.

Why Choose 3µm Streptavidin Magnetic Beads?

Exact 3µm Product Positioning

Many competitors offer2.8µm or2–3µm products. MSA3UM-10 provides an exact nominal3µm specification for customers whose research methods, existing raw-material specifications or automated platforms are based on this particle size.

Established Immunoassay Particle Format

Commercial3µm streptavidin beads are used for capturing biotinylated antibodies, nucleic acids and proteins, and are positioned for automated magnetic separation and high-throughput workflows.

Defined Magnetic Collection

A3µm magnetic bead may produce a clearly defined collection zone under a suitable magnetic field.

Actual collection performance depends on:

• Magnetic loading;

• Magnet strength;

• Bead concentration;

• Sample volume;

• Buffer viscosity;

• Vessel geometry;

• Particle aggregation.

Suitable for Repeated Washing

Chemiluminescence immunoassays commonly require several separation and washing cycles.

MSA3UM-10 may be evaluated for workflows requiring:

• Repeatable bead recovery;

• Controlled aspiration;

• Low particle loss;

• Complete redispersion;

• Consistent residual wash volume;

• Stable assay precision.

Practical Starting Concentration

A1% suspension can provide a convenient starting concentration for:

• Ligand-loading studies;

• Bead-dosage optimization;

• Competitive product comparison;

• Manual assay development;

• Automated reagent formulation;

• Pilot-scale processing.

The working concentration in the final assay should be determined experimentally.

Automated-Platform Evaluation

MSA3UM-10 may be evaluated for automated CLIA or other magnetic immunoassay analyzers.

Parameters requiring validation include:

• Reagent-reservoir mixing;

• Bead-dispensing accuracy;

• Reaction-cup geometry;

• Incubation mixing;

• Magnet position;

• Magnetic collection time;

• Aspiration height;

• Wash volume;

• Residual liquid;

• Bead recovery;

• Redispersion;

• Carryover.

Commercial exact-3µm streptavidin magnetic beads are positioned for automated high-throughput operation, but compatibility remains platform-specific.

3µm vs 2.8µm and 1µm Streptavidin Magnetic Beads

Selecting a particle size requires functional comparison rather than relying only on nominal diameter.

A0.2µm difference between2.8µm and3µm may be less important than differences in:

• Particle-size distribution;

• Magnetic material content;

• Surface coating;

• Streptavidin loading;

• Biotin-binding capacity;

• Blocking formulation;

• Non-specific binding;

• Suspension buffer.

The preferred product should be selected through side-by-side functional testing.

Applications in Chemiluminescence Immunoassay Development

Magnetic Sandwich Immunoassays

A biotinylated capture antibody can be loaded onto MSA3UM-10.

The antibody-loaded particles capture the target antigen from the sample. A labelled detection antibody then forms a sandwich complex.

After magnetic separation and washing, the detection label produces the analytical signal.

Important development variables include:

• Bead dosage;

• Capture-antibody loading;

• Degree of antibody biotinylation;

• Sample volume;

• Capture time;

• Detection-antibody concentration;

• Wash efficiency;

• Signal substrate;

• Signal-to-background ratio.

Direct Chemiluminescence Assays

MSA3UM-10 may be evaluated in direct chemiluminescence formats using a suitable labelled recognition molecule.

Commercial3µm streptavidin beads are specifically marketed for magnetic particle-based chemiluminescence and biotinylated ligand capture.

Performance of MSA3UM-10 must be validated independently in the complete reagent system.

Electrochemiluminescence Assay Research

MSA3UM-10 may be evaluated for electrochemiluminescence immunoassay research.

Compatibility should be confirmed with:

• Magnetic positioning module;

• Electrode configuration;

• Electrochemiluminescent label;

• Reaction buffer;

• Assay consumables;

• Wash sequence;

• Signal-reading program.

Antibody-Detection Assays

A biotinylated antigen can be immobilized on the beads to capture target antibodies from research samples.

Potential applications include:

• Infectious-disease antibody research;

• Autoantibody assays;

• Vaccine-response studies;

• Recombinant antigen evaluation;

• Antibody-response monitoring.

Competitive Immunoassays

Biotinylated antigens, haptens or small-molecule conjugates may be immobilized for competitive assay development.

This format can be evaluated when the analyte cannot support a conventional two-antibody sandwich structure.

Indirect Immunoassay Formats

MSA3UM-10 may also be evaluated with:

• Biotinylated secondary antibodies;

• Biotinylated anti-species antibodies;

• Biotinylated affinity proteins;

• Biotinylated peptides;

• Biotinylated aptamers.

Immunomagnetic Enrichment

Biotinylated affinity ligands loaded onto MSA3UM-10 may be evaluated for enrichment of:

• Proteins;

• Antigens;

• Cells;

• Microorganisms;

• Biological particles;

• Other affinity-recognized targets.

Nucleic Acid and Aptamer Capture

Biotinylated DNA, RNA or aptamer probes may be immobilized for:

• Hybridization assays;

• Nucleic acid enrichment;

• Target capture before amplification;

• Aptamer-based detection;

• Biosensor development;

• Molecular diagnostic research.

Commercial3µm streptavidin beads are used for capturing biotin-labelled antibodies and DNA probes, supporting their use across immunoassay and nucleic acid workflows.

Compatible Biotinylated Antibodies and Biomolecules

Biotinylated Antibodies

Important antibody variables include:

• Antibody purity;

• Antibody concentration;

• Biotinylation chemistry;

• Degree of biotinylation;

• Position of biotin modification;

• Aggregation status;

• Retained antigen-binding activity;

• Original formulation buffer.

Excessive biotinylation may reduce biological activity or produce unfavourable orientation on the magnetic bead surface.

Insufficient biotinylation may reduce bead loading.

Biotinylated Antigens

Biotinylated antigens can be used for antibody-detection assays.

The developer should confirm that biotinylation does not modify or block an important antigenic epitope.

Biotinylated Peptides

Potential applications include:

• Antibody screening;

• Epitope analysis;

• Competitive immunoassays;

• Protein-interaction research;

• Affinity capture.

Biotinylated Oligonucleotides

Biotin may be introduced at the5′ end,3′ end or another validated position.

The selected modification position should preserve hybridization, target recognition or aptamer activity after immobilization.

Biotinylated Proteins and Enzymes

Biotinylated recombinant proteins or enzymes may be evaluated for:

• Protein-interaction studies;

• Enzyme assays;

• Affinity enrichment;

• Biosensor development;

• Calibration-material preparation.

Recommended Biotinylated Ligand Loading Workflow

The following workflow is a general development framework. It is not a validated product-specific protocol.

Step 1: Characterize the Biotinylated Ligand

Record:

• Ligand identity;

• Molecular weight;

• Concentration;

• Purity;

• Original formulation;

• Biotinylation method;

• Estimated degree of biotinylation;

• Biological activity;

• Aggregation status;

• Stabilizing additives.

Step 2: Remove Excess Free Biotin

Free biotin can occupy streptavidin-binding sites and reduce loading of the intended biotinylated antibody, antigen, protein or oligonucleotide.

Spherotech notes that free biotin and unreacted biotinylated primers can bind to streptavidin particles more rapidly than larger biotinylated molecules.

Potential purification methods include:

• Desalting;

• Dialysis;

• Size-exclusion chromatography;

• Ultrafiltration;

• HPLC or FPLC where appropriate;

• Another validated purification method.

Step 3: Fully Resuspend MSA3UM-10

Mix the original suspension until homogeneous before sampling.

Possible methods include:

• Gentle inversion;

• Roller mixing;

• End-over-end rotation;

• Controlled vortexing;

• Another validated mixing method.

Avoid excessive foaming.

Step 4: Calculate the Required Bead Mass

Assuming a concentration of10mg/mL:

Bead mass = suspension volume × 10mg/mL

Prepare multiple bead-dose groups rather than testing only one condition.

Step 5: Wash or Equilibrate the Beads

Collect the particles using a compatible magnetic separator.

Remove the original suspension medium when required and equilibrate the beads in a validated ligand-loading buffer.

Step 6: Add the Biotinylated Ligand

Evaluate several ligand-to-bead ratios.

Possible experimental groups include:

• Low ligand loading;

• Medium ligand loading;

• High ligand loading;

• Different incubation times;

• Different temperatures;

• Different buffer compositions.

Step 7: Maintain Gentle Mixing

Use sufficient mixing to maintain uniform bead–ligand contact without damaging the biological ligand.

Step 8: Magnetically Collect the Loaded Beads

Standardize:

• Magnet type;

• Vessel;

• Reaction volume;

• Bead concentration;

• Collection time;

• Collection position;

• Residual liquid volume.

Step 9: Retain the Supernatant

Retain the post-loading supernatant when ligand-loading efficiency needs to be measured.

Step 10: Wash the Loaded Beads

Remove:

• Unbound biotinylated ligand;

• Residual free biotin;

• Unwanted formulation components;

• Other unbound materials.

Step 11: Resuspend in the Final Buffer

Potential formulation components include:

• Buffer;

• Salt;

• Protein stabilizer;

• Synthetic polymer;

• Surfactant;

• Preservative;

• Sugar or polyol;

• Blocking component.

Step 12: Evaluate Functional Performance

Recommended tests include:

• Ligand-loading efficiency;

• Target-capture capacity;

• Blank signal;

• Positive signal;

• Signal-to-background ratio;

• Magnetic recovery;

• Bead redispersion;

• Precision;

• Accelerated stability;

• Real-time stability.

How to Optimize MSA3UM-10 in an Immunoassay

Optimize Bead Dosage

Compare several bead quantities in the complete assay.

Too few beads may limit target capture.

Too many beads may increase:

• Reagent consumption;

• Blank signal;

• Non-specific adsorption;

• Washing requirements;

• Residual bead interference;

• Instrument carryover.

Optimize Biotinylated Ligand Loading

Evaluate several amounts of biotinylated antibody or antigen per milligram of magnetic beads.

The highest ligand-loading condition is not necessarily the best analytical condition.

Excessive loading may produce:

• Steric crowding;

• Reduced target accessibility;

• Higher non-specific binding;

• Reduced functional activity;

• Poorer storage stability.

Optimize the Degree of Biotinylation

Compare ligands with different biotinylation levels.

Evaluate:

• Bead-loading efficiency;

• Retained biological activity;

• Target-capture performance;

• Blank signal;

• Positive signal;

• Precision;

• Stability.

Optimize Loading Time

The required loading time depends on:

• Ligand size;

• Biotin accessibility;

• Bead concentration;

• Mixing;

• Temperature;

• Buffer composition.

Optimize Blocking and Storage Formulation

Potential formulation variables include:

• Protein blockers;

• Synthetic blocking polymers;

• Nonionic surfactants;

• Ionic strength;

• Sugars;

• Polyols;

• Preservatives.

The final formulation should support particle dispersion, low background, streptavidin activity and ligand stability.

Optimize Magnetic Separation

Evaluate:

• Magnet strength;

• Magnet position;

• Collection time;

• Reaction-vessel geometry;

• Bead concentration;

• Buffer viscosity;

• Residual liquid;

• Bead loss during aspiration.

Optimize Washing

Compare:

• Wash-buffer composition;

• Surfactant concentration;

• Wash volume;

• Number of wash cycles;

• Mixing during washing;

• Magnetic collection time;

• Residual wash volume.

Insufficient washing can increase background. Excessive washing may reduce bead recovery or affect sensitive assay components.

Optimize Automated Analyzer Parameters

For automated CLIA development, evaluate:

• Reagent-reservoir mixing;

• Bead-dispensing accuracy;

• Incubation mixing;

• Magnetic collection time;

• Aspiration height;

• Wash cycles;

• Residual volume;

• Bead redispersion;

• Carryover.

How to Evaluate Biotin-Binding and Functional Performance

Total Biotin-Binding Capacity

A labelled biotin reagent can be used to estimate available streptavidin-binding sites.

Competitors report capacity in units such as picomoles or nanomoles of free biotin per milligram of beads. Results vary substantially with particle structure, surface chemistry and test method.

MSA3UM-10 should have its own validated test method and internal acceptance range.

Biotinylated Antibody Loading

Measure the antibody quantity before and after loading.

An approximate calculation is:

Loaded antibody = Initial antibody − Unbound antibody

Possible analytical methods include:

• UV absorbance;

• BCA assay;

• Bradford assay;

• Fluorescence measurement;

• ELISA;

• Another validated protein assay.

Functional Target-Capture Capacity

Chemical loading does not confirm that the antibody or antigen remains biologically active.

Functional testing should measure actual target capture under representative assay conditions.

Non-Specific Binding

Compare:

• Unloaded streptavidin beads;

• Ligand-loaded beads;

• Blocked beads;

• Negative samples;

• Positive samples;

• Representative interfering materials.

Magnetic Recovery

Measure bead recovery after repeated magnetic collection and washing.

Immunoassay Performance

Evaluate:

• Blank signal;

• Negative-sample signal;

• Low-positive signal;

• High-positive signal;

• Signal-to-background ratio;

• Precision;

• Recovery;

• Linearity;

• Specificity;

• Hook effect;

• Stability.

Quality Control for Research and Batch Production

Appearance and Dispersion

Inspect:

• Suspension appearance;

• Visible aggregation;

• Sedimentation behaviour;

• Homogeneity after mixing;

• Ease of redispersion;

• Stability during process holds.

Particle Size and Distribution

Confirm the nominal3µm particle size using an appropriate validated method.

For batch production, monitor both average particle size and particle-size distribution.

Solids Content

Verify solids concentration because it affects:

• Bead-mass calculations;

• Ligand-loading calculations;

• Assay formulation;

• Filling accuracy;

• Production yield.

Streptavidin Activity

Use a standardized biotin-binding test to evaluate functional streptavidin activity on the particle surface.

Biotin-Binding Capacity

Establish a validated test method and internal acceptance range.

Competitor values should only be used as benchmarking information, not as specifications for MSA3UM-10.

Biotinylated Antibody Loading

Use a representative biotinylated antibody to evaluate practical loading performance.

Magnetic Collection Performance

Standardize:

• Magnet;

• Vessel;

• Sample volume;

• Buffer;

• Bead concentration;

• Temperature;

• Collection time.

Non-Specific Binding

Evaluate background using representative proteins, antibodies and sample matrices.

Functional CLIA Performance

Recommended tests include:

• Blank signal;

• Negative-sample signal;

• Positive-sample signal;

• Signal-to-background ratio;

• Analytical sensitivity;

• Precision;

• Recovery;

• Linearity;

• Specificity;

• Stability.

Lot-to-Lot Consistency

For routine manufacturing, establish acceptance ranges for:

• Particle size;

• Particle-size distribution;

• Solids content;

• Streptavidin activity;

• Biotin-binding capacity;

• Magnetic collection;

• Dispersion;

• Non-specific binding;

• Functional immunoassay performance.

Final raw-material approval should be based on performance in the complete assay system.

Scale-Up and Bulk Supply for Immunoassay Manufacturers

Evaluation Stage

Evaluation samples can support screening of:

• Biotinylated capture antibodies;

• Biotinylated antigens;

• Bead dosage;

• Ligand-loading level;

• Blocking formulation;

• Magnetic separation;

• Assay sensitivity;

• Background signal.

Pilot-Scale Stage

Pilot quantities can support:

• Ligand-loading process confirmation;

• Reagent formulation;

• Analyzer compatibility testing;

• Stability studies;

• Filling-process evaluation;

• Initial lot-consistency testing.

Batch-Production Stage

Bulk-supply planning may include:

• Annual demand;

• Purchasing forecast;

• Packaging volume;

• Quality specifications;

• Technical documentation;

• Quality documentation;

• Reserved-lot requirements;

• Change-control expectations;

• Safety-stock planning.

Official product specifications from several suppliers include2mL,10mL and100mL formats for3µm or neighbouring-size streptavidin beads, showing that scalable packaging is an important purchasing requirement.

Scale-Up Considerations

A laboratory ligand-loading procedure should not be scaled only by multiplying reagent volumes.

Revalidate:

• Vessel geometry;

• Mixing efficiency;

• Bead homogeneity;

• Ligand-addition sequence;

• Incubation time;

• Temperature uniformity;

• Magnetic collection;

• Washing efficiency;

• Process hold time;

• Final filling uniformity.

Custom Streptavidin Magnetic Bead Services

Customized product requirements may be evaluated for biotechnology companies, research institutions and immunoassay manufacturers.

Potential customization options include:

• Alternative particle sizes;

• Customized solids content;

• Adjusted streptavidin loading;

• Customer-specific biotin-binding targets;

• Alternative blocking systems;

• Customized suspension buffer;

• Alternative preservatives;

• Customer-specified pH;

• Special packaging volumes;

• Pilot-scale manufacturing;

• Bulk manufacturing;

• OEM packaging;

• Private-label services;

• Customer-specific quality testing.

Customization feasibility depends on the requested specification, intended application, validation requirements and order quantity.

Storage and Handling Recommendations

Store MSA3UM-10 according to the product label, technical data sheet and lot-specific certificate of analysis.

General handling recommendations include:

• Mix thoroughly before sampling;

• Maintain suspension uniformity during dispensing;

• Use clean and calibrated equipment;

• Avoid allowing the magnetic beads to dry;

• Prevent microbial and chemical contamination;

• Avoid freezing unless specifically validated;

• Avoid unnecessary exposure to extreme temperatures;

• Confirm buffer compatibility before buffer exchange;

• Prevent contamination with free biotin;

• Record the product lot number;

• Evaluate ligand-loaded bead stability separately.

Commercial streptavidin magnetic particle instructions commonly recommend refrigerated storage, maintaining the particles in liquid and avoiding conditions that cause drying or aggregation. Product-specific conditions for MSA3UM-10 must be confirmed using its own documentation.

Frequently Asked Questions

What is MSA3UM-10?

MSA3UM-10 is a3µm streptavidin-functional magnetic bead suspension supplied at1% solids for capturing biotinylated biomolecules in immunoassay research, CLIA development and batch manufacturing.

What does 1% solids mean?

When expressed as w/v,1% solids corresponds to approximately10mg of magnetic beads per milliliter of suspension.

Which molecules can MSA3UM-10 capture?

The beads can be evaluated for binding biotinylated antibodies, antigens, proteins, peptides, aptamers, DNA, RNA and other biotin-labelled molecules.

What is the binding principle?

Biotin on the selected ligand binds to streptavidin immobilized on the magnetic bead surface.

Does MSA3UM-10 require EDC or NHS activation?

No additional EDC/NHS bead activation is normally required for loading a properly biotinylated ligand.

Is a capture antibody included?

No. MSA3UM-10 is supplied as a streptavidin magnetic bead raw material. The customer selects and prepares the required biotinylated capture ligand.

Is the 1% suspension ready to use directly?

Not necessarily. The optimal working concentration depends on the ligand, target concentration, assay volume, sample matrix and analyzer.

Why choose a 3µm particle size?

The3µm format can be evaluated when the assay requires an exact micrometer-scale magnetic carrier with defined magnetic collection, repeated washing and compatibility with an existing3µm raw-material specification.

What is the difference between 2.8µm and 3µm beads?

The nominal size difference is small. Performance may be affected more strongly by particle-size distribution, magnetic loading, surface chemistry, streptavidin density, blocking system and suspension formulation.

What is the difference between 1µm and 3µm beads?

The two sizes generally differ in particle number per unit mass, geometric surface area, sedimentation and magnetic collection. The preferred size should be selected through side-by-side functional testing.

Can MSA3UM-10 be used for chemiluminescence immunoassays?

It can be evaluated as a magnetic solid phase in CLIA development. Compatibility with the complete reagent system and analyzer must be validated.

Can it be evaluated for electrochemiluminescence assays?

Yes, it may be evaluated in ECL research. Compatibility with the electrode, magnetic positioning system, fluidics and signal chemistry must be confirmed experimentally.

Can MSA3UM-10 be used with automated analyzers?

It may be evaluated for automated systems. Dispensing, mixing, magnetic collection, aspiration, washing and redispersion must be validated on the specific analyzer.

How much biotinylated antibody should be loaded?

The optimal amount depends on the product’s validated binding capacity, antibody molecular weight, degree of biotinylation and assay requirements. Several loading levels should be compared.

Does more antibody always improve sensitivity?

No. Excessive ligand loading may cause steric crowding, reduce target accessibility and increase non-specific binding.

Can free biotin interfere with loading?

Yes. Free biotin can occupy available streptavidin-binding sites and reduce loading of the intended biotinylated ligand.

How can ligand-loading efficiency be measured?

Compare the initial ligand amount with the quantity remaining in the post-loading supernatant. Functional target-capture activity should also be measured.

Can non-biotinylated antibodies bind specifically?

Non-biotinylated antibodies are not expected to bind specifically through the streptavidin–biotin interaction. Observed binding may result from non-specific adsorption.

How should MSA3UM-10 be mixed?

Mix using a validated method such as inversion, roller mixing, end-over-end rotation or controlled vortexing until the suspension is homogeneous.

What should be checked if magnetic collection is incomplete?

Check:

• Magnet strength;

• Collection time;

• Bead concentration;

• Buffer viscosity;

• Particle aggregation;

• Vessel geometry.

What should be checked if ligand loading is low?

Evaluate:

• Degree of biotinylation;

• Free biotin contamination;

• Ligand concentration;

• Bead quantity;

• Loading time;

• Buffer compatibility;

• Ligand aggregation.

What should be checked if assay background is high?

Evaluate:

• Blocking formulation;

• Bead dosage;

• Ligand-loading density;

• Wash efficiency;

• Sample matrix;

• Non-specific adsorption;

• Detection-reagent concentration.

Is MSA3UM-10 a finished diagnostic reagent?

No. MSA3UM-10 is supplied as a raw material for research and reagent development. The customer is responsible for validating the finished reagent, production process and intended application.

Are evaluation samples available?

Evaluation samples can be discussed according to the intended application, biotinylated ligand and required testing quantity.

Is bulk supply available?

Pilot-scale and bulk supply may be arranged for qualified research, development and manufacturing projects.

Can the concentration, buffer or packaging be customized?

Customized solids content, streptavidin loading, suspension buffer, blocking system and packaging format may be evaluated according to project requirements.

Request a Sample or Bulk Quotation

Contact SHBC to request an evaluation sample, technical information or bulk quotation for MSA3UM-10 3µm Streptavidin Magnetic Beads.

Please provide:

• Intended immunoassay application;

• Biotinylated antibody, antigen or other ligand;

• Ligand molecular weight;

• Biotinylation method;

• Estimated degree of biotinylation;

• Required evaluation quantity;

• Estimated pilot quantity;

• Expected annual demand;

• Preferred packaging volume;

• Required technical documents;

• Required quality documents;

• Target development schedule;

• Custom specification requirements.

SHBC supports streptavidin magnetic bead projects from early ligand-loading evaluation and immunoassay optimization to pilot production and bulk manufacturing.